Merck & Co. to Acquire Harpoon Therapeutics for US$680 M

By Ayush Saxena

Pharma Deals Review: Vol 2024 Issue 2 (Table of Contents)

Published: 2 Feb-2024

DOI: 10.3833/pdr.v2024.i2.2851     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

In order to expand its oncology portfolio, Merck has agreed to acquire Harpoon Therapeutics for US$680 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details